IL-15 Enhances Survival and Function of HIV-specific CD8+ T Cells
Overview
Authors
Affiliations
HIV-specific CD8(+) T cells are prone to undergo apoptosis, and this may affect their ability to control HIV infection. Because CD8-mediated immune responses play a key role in controlling HIV infection, enhancing the survival and effector function of HIV-specific CD8(+) T cells may augment their ability to control HIV virus. We show here that interleukin 15 (IL-15) potently inhibits spontaneous and CD95/Fas-induced apoptosis of HIV-specific CD8(+) T cells. IL-15 inhibits apoptosis in both CD45RA(-)CD62L(-) and CD45RA(+)CD62L(-) effector memory subpopulations of these cells. Furthermore, IL-15 greatly enhances the survival of HIV-specific CD8(+) T cells in long-term cultures. Finally, IL-15 directly enhances activation, interferon gamma (IFNgamma) production, and direct ex vivo cytotoxicity of HIV-specific CD8(+) T cells. Thus, IL-15 potently enhances the survival and effector function of HIV-specific CD8(+) T cells and, therefore, may prove useful in augmenting the antiviral function of these cells.
Liang H, Cao Z, Ren Y, Li Y, Wang H, Sun F Front Immunol. 2025; 16:1516946.
PMID: 40070829 PMC: 11893875. DOI: 10.3389/fimmu.2025.1516946.
From natural defenders to therapeutic warriors: NK cells in HIV immunotherapy.
Laeremans T, Janssens A, Aerts J Immunotherapy. 2025; 17(2):133-145.
PMID: 39905963 PMC: 11901454. DOI: 10.1080/1750743X.2025.2460965.
Isotretinoin promotes elimination of translation-competent HIV latent reservoirs in CD4T cells.
Howard J, Levinger C, Deletsu S, Fromentin R, Chomont N, Bosque A PLoS Pathog. 2024; 20(10):e1012601.
PMID: 39401241 PMC: 11501018. DOI: 10.1371/journal.ppat.1012601.
IL-15 in T-Cell Responses and Immunopathogenesis.
Lee H, Park S, Shin E Immune Netw. 2024; 24(1):e11.
PMID: 38455459 PMC: 10917573. DOI: 10.4110/in.2024.24.e11.
Immunomodulation with IL-7 and IL-15 in HIV-1 infection.
Gunst J, Goonetilleke N, Rasmussen T, Sogaard O J Virus Erad. 2023; 9(3):100347.
PMID: 37767312 PMC: 10520363. DOI: 10.1016/j.jve.2023.100347.